Pfizer’s Not Waiting To Exhale; Firm Takes Action By Terminating Exubera
After the inhaled insulin failed to gain traction, Pfizer also has decided to stop funding investment in a second generation device.
After the inhaled insulin failed to gain traction, Pfizer also has decided to stop funding investment in a second generation device.